Advertisement
Advertisement

IMNN

IMNN logo

Imunon, Inc. Common Stock

3.31
USD
Sponsored
0.00
0.00%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

3.35

+0.04
+1.18%

IMNN Earnings Reports

Positive Surprise Ratio

IMNN beat 20 of 38 last estimates.

53%

Next Report

Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.35
Implied change from Q3 25 (Revenue/ EPS)
--
/
+17.39%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-70.39%

Imunon, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, IMNN reported earnings of -1.15 USD per share (EPS) for Q3 25, beating the estimate of -1.84 USD, resulting in a 37.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -1.35 USD, with revenue projected to reach -- USD, implying an increase of 17.39% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Imunon, Inc. Common Stock reported EPS of -$1.15, beating estimates by 37%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.32%, changed from $3.95 before the earnings release to $4.16 the day after.
The next earning report is scheduled for Feb 25, 2026.
Based on 6 analysts, Imunon, Inc. Common Stock is expected to report EPS of -$1.35 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement